Index Adjustments on the Occasion of the Ordinary Index Review

SIX has decided to make changes to the index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 19 September 2025 after closing. The adjustment takes effect on 22 September 2025.

Index Adjustments on the Occasion of the Ordinary Index Review
Published at
Medium
Media

Amrize qualifies for remaining in the SMI, SPI20, SLI, and SPI Large indices based on the updated selection list.

Changes to the SMI® and SPI®20 index baskets

Exclusion from the SMI® and SPI®20

SONOVA N

 CH0012549785


Changes to the SMIM® index basket

Admission to the SMIM®

SONOVA N

 CH0012549785

SWISSQUOTE N

 CH0010675863

ACCELLERON N

 CH1169360919

SUNRISE N

 CH1386220409


Exclusion from the SMIM®

ams-OSRAM

 AT0000A3EPA4

BKW N

 CH0130293662

TECAN GROUP AG N

 CH0012100191

GALENICA N

 CH0360674466

 

Changes to the SLI® index basket

Admission to the SLI®

Galderma Group N

 CH1335392721

 

Exclusion from the SLI®

ADECCO N

 CH0012138605

SIG Group N

 CH0435377954

 

SLI® 9% cappings

Based on the SLI® index rules, section 5.16.4, and according to the capping selection list 9%1, the weight of the following securities will be limited to 9%:

NESTLE N

 CH0038863350

NOVARTIS N

 CH0012005267

ROCHE GS

 CH0012032048
UBS GROUP N CH0244767585

 

Changes to the SPI® Small, Mid and Large index baskets

Changes from SPI® Mid to SPI® Large

NO CHANGES

  


Changes from SPI® Large to SPI® Mid

KUEHNE+NAGEL INT N

 CH0025238863


Changes from SPI® Small to SPI® Mid

LIECHT LANDBK N

 LI0355147575

BURKHALTER N

 CH0212255803

MEDACTA GROUP N

 CH0468525222

 

Changes from SPI® Mid to SPI® Small

DocMorris N

 CH0042615283

KOMAX N

 CH0010702154

BYSTRONIC N

 CH0244017502

LEM N

 CH0022427626

 

Changes to the SXI Life Sciences®

Admission to the SXI Life Sciences®

SANTHERA N

 CH1276028821

 

Exclusion from the SXI Life Sciences®

XLIFE SCIENCES N

 CH0461929603

 

Changes to the SXI Bio+Medtech®

Admission to the SXI Bio+Medtech®

SANTHERA N

 CH1276028821

 

Exclusion from the SXI Bio+Medtech®

XLIFE SCIENCES N

 CH0461929603


Changes to the SXI Swiss Real Estate® Funds

NO CHANGES TO THE INDEX COMPOSITION

  


Changes to the SXI Swiss Real Estate® Shares

NO CHANGES TO THE INDEX COMPOSITION

  

 

Further Links

The equity selection list, which is compiled four times a year on the basis of the admission and exclusion criteria, is available on the website[1]:

[1] Access to the Closed User Group required.

Any questions?

Please do not hesitate to contact Julian Chan.

Generate PDF

 
About SIX
SIX serves the Swiss and Spanish financial centers and a broad international client base, offering stable and efficient infrastructure services. SIX operates stock exchanges and provides services in post trading, financial information as well as the payments business. The company is owned by its users (about 120 financial institutions). With over 4,400 employees and a presence in 19 countries, SIX generated operating income of CHF 1.6 billion and EBITDA of CHF 443.7 million in 2024.
www.six-group.com

View all Media Releases